Interleukin-27 subunit beta (IL-27b) (Middle Region) Peptide
IL-27b
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all EBI3 (IL-27b) products
- EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- TAVHPWGSSS SFVPFITEHI IKPDPPEGVR LSPLAERQLQ VQWEPPGSWP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EBI3 Antibody(ARP42257_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))
- Target Type
- Viral Protein
- Background
-
This gene was identified by its induced expression in B lymphocytes in response Epstein-Barr virus infection. It encodes a secreted glycoprotein belonging to the hematopoietin receptor family, and heterodimerizes with a 28 kDa protein to form interleukin 27 (IL-27). IL-27 regulates T cell and inflammatory responses, in part by activating the Jak/STAT pathway of CD4+ T cells.
Alias Symbols: IL27B, IL-27B
Protein Interaction Partner: CANX,GOSR1,IL12A,IL27RA,MDFI,SMAD3,CANX,GOSR1,IL27RA,MDFI
Protein Size: 229 - Molecular Weight
- 23 kDa
- Gene ID
- 10148
- NCBI Accession
- NM_005755, NP_005746
- UniProt
- Q14213
-
You are here:
